🇺🇸 FDA
Pipeline program

Exparel + Bupivacaine

402-C-411

Approved small_molecule completed

Quick answer

Exparel + Bupivacaine for C-Section is a Approved program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
C-Section
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials